Cargando…
Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
Psoriasis is a frequent, chronic disease characterized by cutaneous inflammatory plaques and/or arthritis. It may be associated with few other diseases, mainly Crohn’s disease and metabolic syndrome. The medical and psychosocial burden of psoriasis remains high even since biological treatments arose...
Autores principales: | Bugaut, Hélène, Aractingi, Sélim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948519/ https://www.ncbi.nlm.nih.gov/pubmed/33717124 http://dx.doi.org/10.3389/fimmu.2021.621956 |
Ejemplares similares
-
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
por: Ceribelli, Angela, et al.
Publicado: (2021) -
The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
por: Schön, Michael P., et al.
Publicado: (2018) -
The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
por: Vecellio, Matteo, et al.
Publicado: (2021) -
The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017) -
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)